Target intelligence / Profile preview

Viral 3C protease (3Cpro) (3Cpro)

Target
3Cpro
Molecular classification
Enzyme, Cysteine protease, Hydrolase
01

Overview

Viral 3C protease is a critical chymotrypsin-like cysteine protease encoded by viruses in the Picornaviridae family, including human rhinovirus, poliovirus, and enterovirus 71 (UniProt, 2023). Its primary biological role is the site-specific cleavage of the viral polyprotein into mature structural and non-structural proteins, a step that is indispensable for viral replication and the assembly of new virions (PubMed, 2021).\n\nIn addition to its role in the viral life cycle, the 3C protease targets and degrades various host cell proteins, such as TATA-binding protein and poly(A)-binding protein, to shut down host cell transcription and translation, thereby facilitating viral dominance and immune evasion (Wikipedia, 2024). Because the enzyme's substrate preference for glutamine at the P1 position is not shared by human cellular proteases, it represents a highly selective target for antiviral drug design (NCBI PubChem, 2024). Therapeutic agents like rupintrivir (AG7088) are designed as peptidomimetic inhibitors that covalently bind to the active site cysteine, effectively halting the progression of viral infections (Matthews et al., 1999). While primarily associated with picornaviruses, the 3C-like protease (3CLpro) found in coronaviruses shares significant structural and functional similarities, making this class of enzymes a cornerstone of modern antiviral research (Zhang et al., 2020).

Other names
3C protease3C cysteine proteasePicornain 3C3CLproMain proteaseMpro
02

Mechanism of action

Inhibition of the viral protease activity by binding to the active site (often covalently to the catalytic cysteine residue), preventing the cleavage of the viral polyprotein into functional units (NCBI PubChem, 2024).

03

Biological functions

Viral polyprotein processingViral replicationHost cell protein degradationInhibition of host transcription
04

Disease associations

InfectionCommon coldPoliomyelitisHand-foot-and-mouth diseaseCOVID-19
05

Safety considerations

Potential off-target effects on host proteasesRapid emergence of drug-resistant viral mutationsBioavailability challenges for peptidomimetic compounds
06

Interacting drugs

Rupintrivir

3 more in the full profile.

07

Biomarkers

Viral loadViral RNA levelsProtease activity assays

Beyond the preview

Go deeper on Viral 3C protease (3Cpro) (3Cpro).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Viral 3C protease (3Cpro) (3Cpro).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call